Research
Our research focuses the dissection of mechanisms that underlie response and resistance to immunotherapies and on the longitudinal tracking of tumor cell evolution using single-cell lineage-tracing approaches based on interrogation of natural barcodes like somatic nuclear or mitochondrial DNA mutations.
Highlighted
Tracking rare single donor and recipient immune and leukemia cells after allogeneic hematopoietic cell transplantation using mitochondrial DNA mutations
Blood Cancer Discovery
·
05 Sep 2024
·
doi:10.1158/2643-3230.BCD-23-0138
Single-cell tracking of clonal evolution and microchimerism using mitochondrial DNA mutations
Integrative genotyping of cancer and immune phenotypes by long-read sequencing
Nature Communications
·
02 Jan 2024
·
doi:10.1038/s41467-023-44137-7
Targeted genotyping of scRNA-seq cDNA libraries using long-read sequencing with Oxford Nanopore
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease
Blood
·
13 Apr 2023
·
doi:10.1182/blood.2022018246
Single cell RNA sequencing analysis dissecting responses to ipilimumab treatment of relapsed AML/MDS with and without stem cell transplantation.
Longitudinal Single-Cell Dynamics of Chromatin Accessibility and Mitochondrial Mutations in Chronic Lymphocytic Leukemia Mirror Disease History
Cancer Discovery
·
01 Dec 2021
·
doi:10.1158/2159-8290.CD-21-0276
First demonstration that longitudinal changes of mitochondrial DNA mutations reflect therapeutic bottlenecks.
All
2024
Therapy response in AML: a tale of two T cells
Blood
·
12 Sep 2024
·
doi:10.1182/blood.2024024593
Commentary on Mazziotta et al
Tracking rare single donor and recipient immune and leukemia cells after allogeneic hematopoietic cell transplantation using mitochondrial DNA mutations
Blood Cancer Discovery
·
05 Sep 2024
·
doi:10.1158/2643-3230.BCD-23-0138
Single-cell tracking of clonal evolution and microchimerism using mitochondrial DNA mutations
A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia
Leukemia
·
26 Aug 2024
·
doi:10.1038/s41375-024-02381-w
Immune cell networks in pediatric and adult acute myeloid leukemia
Artifacts in single-cell mitochondrial DNA mutation analyses misinform phylogenetic inference
Cold Spring Harbor Laboratory
·
29 Jul 2024
·
doi:10.1101/2024.07.28.605517
Commentary on problematic analyses of mitochondrial DNA mutations
Oncogene induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice
Journal of Clinical Investigation
·
25 Jun 2024
·
doi:10.1172/JCI177460
TIM-3 inhibition stimulates graft-versus-leukemia responses against AML
Single-cell genomics-based immune and disease monitoring in blood malignancies
Clinical Hematology International
·
14 Jun 2024
·
doi:10.46989/001c.117961
Single-cell genomics-based immune and disease monitoring in blood malignancies
Integrative genotyping of cancer and immune phenotypes by long-read sequencing
Nature Communications
·
02 Jan 2024
·
doi:10.1038/s41467-023-44137-7
Targeted genotyping of scRNA-seq cDNA libraries using long-read sequencing with Oxford Nanopore
2023
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer
Science Immunology
·
29 Sep 2023
·
doi:10.1126/sciimmunol.adf4968
First demonstration that preexisting tumor-resident T cells associate with response to neoadjuvant anti-PD-1 in head and neck cancer
Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease
Blood
·
13 Apr 2023
·
doi:10.1182/blood.2022018246
Single cell RNA sequencing analysis dissecting responses to ipilimumab treatment of relapsed AML/MDS with and without stem cell transplantation.
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings
Blood
·
13 Apr 2023
·
doi:10.1182/blood.2022017686
Clinical study of CTLA-4 blockade and decitabine in relapsed AML/MDS with or without stem cell transplantation.
2022
In VivoModeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities
Blood Cancer Discovery
·
06 Dec 2022
·
doi:10.1158/2643-3230.BCD-22-0082
Mitochondrial DNA Mutations as Natural Barcodes for Lineage Tracing of Murine Tumor Models
Cancer Research
·
05 Dec 2022
·
doi:10.1158/0008-5472.CAN-22-0275
First demonstration of mtDNA mutation-based lineage-tracing in murine cancer models.
Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple Myeloma
Cancer Immunology Research
·
19 Sep 2022
·
doi:10.1158/2326-6066.CIR-22-0434
AML relapse after a TIGIT race
Blood
·
15 Sep 2022
·
doi:10.1182/blood.2022017614
Comment on Gournay et al. describing post-transplant immune reconstitution dynamics.
Rapid single-cell identification of Epstein–Barr virus-specific T-cell receptors for cellular therapy
Cytotherapy
·
01 Aug 2022
·
doi:10.1016/j.jcyt.2022.03.005
Improved T-cell Immunity Following Neoadjuvant Chemotherapy in Ovarian Cancer
Clinical Cancer Research
·
20 Apr 2022
·
doi:10.1158/1078-0432.CCR-21-2834
Natural Barcodes for Longitudinal Single Cell Tracking of Leukemic and Immune Cell Dynamics
Frontiers in Immunology
·
03 Jan 2022
·
doi:10.3389/fimmu.2021.788891
2021
Longitudinal Single-Cell Dynamics of Chromatin Accessibility and Mitochondrial Mutations in Chronic Lymphocytic Leukemia Mirror Disease History
Cancer Discovery
·
01 Dec 2021
·
doi:10.1158/2159-8290.CD-21-0276
First demonstration that longitudinal changes of mitochondrial DNA mutations reflect therapeutic bottlenecks.
Coevolving JAK2V617F+relapsed AML and donor T cells with PD-1 blockade after stem cell transplantation: an index case
Blood Advances
·
18 Nov 2021
·
doi:10.1182/bloodadvances.2021004335
Integrated analysis of exceptional response to PD-1 inhibition in relapsed sAML after allogeneic stem cell transplantation with scRNA-seq, CITE-seq, scATAC-seq and CyTOF.
Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation
Blood
·
16 Mar 2021
·
doi:10.1182/blood.2021010867
Dissection of exceptional responses to CTLA-4 blockade in relapsed leukemia cutis after allogeneic stem cell transplantation.
2020
Personal tumor antigens in blood malignancies: genomics-directed identification and targeting
Journal of Clinical Investigation
·
27 Jan 2020
·
doi:10.1172/JCI129209
Review of targets for cellular immunotherapies in blood malignancies.
2019
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
European Journal of Immunology
·
01 Oct 2019
·
doi:10.1002/eji.201970107
Best practices for flow cytometry.
Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer
OncoImmunology
·
24 Mar 2019
·
doi:10.1080/2162402X.2019.1586409
Phenotypes and T cell receptor sequences of tumor-infiltrating lymphocytes compared to physiologic tissue-resident T cells.
2018
FACS single cell index sorting is highly reliable and determines immune phenotypes of clonally expanded T cells
European Journal of Immunology
·
03 Apr 2018
·
doi:10.1002/eji.201847507
Demonstration of the high accuracy of FACS index sorting using single T and B cell receptor sequencing.
2017
Clonal Expansion and Interrelatedness of Distinct B-Lineage Compartments in Multiple Myeloma Bone Marrow
Cancer Immunology Research
·
31 Aug 2017
·
doi:10.1158/2326-6066.cir-17-0012
Identification of myeloma clones in phenotypically healthy B cell compartment using B cell receptor sequencing.
2015
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
Leukemia
·
31 Jul 2015
·
doi:10.1038/leu.2015.212
A rapid screening system evaluates novel inhibitors of DNA methylation and suggests F-box proteins as potential therapeutic targets for high-risk neuroblastoma
Targeted Oncology
·
06 Jan 2015
·
doi:10.1007/s11523-014-0354-5